Allergy Diagnostics Market Size to Touch $13.71 Billion by 2032

The global Allergy Diagnostics Market is poised for strong growth, with the market size valued at USD 5.77 billion in 2023. The market is projected to increase from USD 6.24 billion in 2024 to USD 13.71 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.3% over the forecast period (2024–2032). The market’s momentum is being driven by increasing allergy prevalence, growing awareness, and technological advancements in diagnostic tools.

As allergic conditions—from respiratory and food allergies to drug-induced and skin-related hypersensitivities—continue to rise globally, accurate and early diagnosis is becoming critical. The growing use of molecular diagnostics, automated analyzers, and at-home allergy testing solutions is significantly shaping the future of the industry.

Market Overview

Allergy diagnostics refers to testing methods and tools used to determine an individual's allergic sensitivities. These tests help identify allergens responsible for reactions such as hay fever, asthma, eczema, food intolerance, and anaphylaxis. With climate change, pollution, processed foods, and genetic predispositions contributing to allergy cases globally, healthcare systems are shifting focus to early, effective diagnosis.

Advances in immunoassays, molecular allergen profiling, and point-of-care (PoC) technologies are making allergy diagnostics more precise, patient-friendly, and accessible, particularly in primary care settings.

???????????????????????????? ???????????? ???????????????????????????????? ???????????????????????????????????????????????????? ???????????????????????? ????????????????:
https://www.polarismarketresearch.com/industry-analysis/allergy-diagnostics-market

Key Market Drivers

Rising Global Allergy Burden: According to the World Allergy Organization, up to 40% of the global population may be affected by allergic conditions, making diagnostics essential for disease management.
Growth in Food and Environmental Allergies: Increasing urbanization, processed diets, and pollution have contributed to the surge in food, pollen, dust mite, and animal-related allergies.
Technological Innovation: Automated systems, AI-based interpretation, and at-home test kits are improving turnaround times and diagnostic accuracy.
Public Awareness & Screening Programs: Greater education and healthcare policies supporting allergy screening, especially in children, are bolstering demand.

Market Segmentation

The Allergy Diagnostics Market is segmented by product & service, test type, allergen type, end-user, and region.

By Product & Service:

Consumables
- Assay Kits
- Antibodies
- Reagents
Instruments
- Immunoassay Analyzers
- Luminometers
- ELISA Readers
Services

Consumables hold the largest share due to their recurring usage in testing workflows. The continuous development of specific IgE detection kits and skin prick test solutions drives growth in this segment.

By Test Type:

In Vivo Tests
- Skin Prick Tests
- Patch Tests
- Intradermal Tests
In Vitro Tests
- Immunoassays (ELISA, CLIA, etc.)
- Allergen-specific IgE Tests
- Molecular Diagnostics

In vitro tests are gaining popularity owing to their high precision, non-invasive nature, and applicability across patient populations, especially in children or those with severe reactions.

By Allergen Type:

Food Allergens
- Peanuts, Tree Nuts, Dairy, Eggs, Shellfish, Soy, Wheat
Inhaled Allergens
- Pollen, Dust Mites, Mold, Animal Dander
Drug Allergens
- Antibiotics (e.g., penicillin), NSAIDs
Other Allergens
- Insect Venom, Latex, Metals

Inhaled allergens dominate the market due to the widespread prevalence of asthma and allergic rhinitis. However, food allergens are witnessing rapid growth driven by rising pediatric allergies and public awareness.

By End-User:

Diagnostic Laboratories
Hospitals and Clinics
Academic Research Institutes
Pharmaceutical and Biotechnology Companies

Diagnostic laboratories lead the segment due to high throughput, advanced infrastructure, and growing outsourcing of allergy testing. Hospitals and clinics are expected to grow rapidly as more allergy testing shifts to outpatient and PoC settings.

Regional Analysis

North America

North America accounted for the largest market share in 2023 and is expected to maintain its lead. Key growth drivers include:

High allergy prevalence (especially food and respiratory)
Advanced diagnostic infrastructure
Favorable reimbursement policies
Robust research and development

The U.S. leads the region, with growing demand for direct-to-consumer (DTC) testing and FDA-approved allergy panels.

Europe

Europe is a mature yet innovation-focused market, with Germany, the U.K., and France at the forefront. The region benefits from:

Strong government support for allergy screening in children
A rising number of accredited labs
Widespread adoption of molecular allergen component diagnostics

Asia Pacific

Asia Pacific is poised for the fastest CAGR, driven by:

Rapid urbanization and increasing exposure to allergens
Growing awareness of food allergies and asthma
Expanding middle class with access to private healthcare
Rising diagnostic lab networks in China, India, and Japan

Latin America & Middle East and Africa

Emerging markets in these regions show promising growth potential due to improving healthcare access, increasing diagnosis rates, and investments in local laboratory infrastructure. Brazil, UAE, and South Africa are notable contributors.

Key Companies in the Market

The Allergy Diagnostics Market is moderately consolidated, with global and regional players vying for innovation leadership and clinical validation. Key strategies include acquisitions, product launches, and strategic collaborations.

Leading Market Players Include:

Thermo Fisher Scientific Inc.
- Market leader in in vitro diagnostics with the ImmunoCAP™ platform for allergen-specific IgE testing.
Stallergenes Greer
- A pioneer in allergen immunotherapy and diagnostics, offering over 1200 allergen extracts.
Siemens Healthineers
- Offers advanced immunoassay systems integrated with allergy diagnostics panels.
bioMérieux SA
- Provides cutting-edge diagnostics with a focus on laboratory automation and infectious disease co-detection.
Danaher Corporation (Beckman Coulter)
- Manufactures allergen detection platforms and immunodiagnostic solutions.
Hitachi Chemical Diagnostics Inc.
- Known for microarray-based allergy testing platforms, especially in Japan and the U.S.
HYCOR Biomedical
- Specializes in allergy and autoimmune diagnostic assays with its NOVEOS® Immunoanalyzer.
R-Biopharm AG
- Offers ELISA and lateral flow assays for food allergens, suitable for clinical and food safety labs.
Euroimmun AG (PerkinElmer)
- Develops allergen component diagnostics and multiplexing allergy assays.
Omega Diagnostics Group PLC
- UK-based provider of allergy, food intolerance, and autoimmune testing solutions.

Recent Developments

Q1 2025: Thermo Fisher announced a partnership with a major pediatric hospital network in the U.S. to expand access to its ImmunoCAP rapid allergy panels.
December 2024: Siemens Healthineers launched a new automated allergy testing module integrated into its Atellica platform.
August 2024: Euroimmun introduced a CE-marked multiplex allergy panel covering 300 allergens in a single assay.
March 2024: HYCOR Biomedical expanded its reach into Asia Pacific by opening a diagnostics hub in Singapore.

Future Outlook

The Allergy Diagnostics Market is evolving rapidly with the integration of machine learning, microarray technology, and personalized medicine. Moving forward, key growth opportunities will stem from:

Home-based allergy test kits with app-based results
AI-driven interpretation of allergen exposure trends
Expansion of testing into primary care and wellness settings
Development of region-specific allergen panels

As allergic conditions continue to rise and early diagnosis becomes a healthcare priority, the market will benefit from innovations that make testing faster, more accurate, and widely accessible. Companies that focus on patient-centric solutions, real-world data, and regulatory compliance will be best positioned for success.

???????????????????????? ???????????????? ???????????????????????????????? ????????????????????????????:

Sickle Cell Disease Treatment Market

Halal Pharmaceuticals Market

Gaucher Disease Treatment Market

Pharmaceutical Robot Market

Liquid Biopsy Market

Medical Tourism Market

Malaria Vaccines Market

Cell Banking Outsourcing Market

Cardiac Rhythm Management Devices Market

Scaffold Technology Market

Chemiluminescence Immunoassay Market